|
EXOSC10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.500600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.510400E-01 |
| Normal-vs-Stage2 |
7.630000E-01 |
| Normal-vs-Stage3 |
5.611800E-01 |
| Normal-vs-Stage4 |
9.420600E-01 |
| Stage1-vs-Stage2 |
4.637800E-01 |
| Stage1-vs-Stage3 |
3.043800E-01 |
| Stage1-vs-Stage4 |
7.767000E-01 |
| Stage2-vs-Stage3 |
8.893600E-01 |
| Stage2-vs-Stage4 |
7.859800E-01 |
| Stage3-vs-Stage4 |
6.460600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.906600E-01 |
| Normal-vs-AfricanAmerican |
7.799000E-01 |
| Normal-vs-Asian |
6.512600E-01 |
| Caucasian-vs-AfricanAmerican |
7.512200E-01 |
| Caucasian-vs-Asian |
6.050800E-01 |
| AfricanAmerican-vs-Asian |
6.627000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.899000E-01 |
| Normal-vs-Female |
1.159990E-01 |
| Male-vs-Female |
7.720100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.863800E-01 |
| Normal-vs-Extreme_Weight |
9.227400E-01 |
| Normal-vs-Obese |
7.870800E-01 |
| Normal-vs-Extreme_Obese |
6.639600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.458200E-01 |
| Normal_Weight-vs-Obese |
7.962200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.371400E-01 |
| Extreme_Weight-vs-Obese |
7.121200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.617400E-01 |
| Obese-vs-Extreme_Obese |
5.426200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.446100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.373400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.073400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.557600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.816400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.639600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.261600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.258360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.343400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.539400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.668040E-01 |
| Normal-VS-Type2 PRCC |
8.206000E-02 |
| Normal-VS-KIRP CIMP |
7.999500E-02 |
| Normal-VS-Unclassified PRCC |
4.915400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.026400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.451200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.518800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.235900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.820100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.901000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.524200E-01 |
| Normal-vs-N1 |
4.113200E-01 |
| Normal-vs-N2 |
1.468000E-01 |
| N0-vs-N1 |
7.792000E-02 |
| N0-vs-N2 |
4.477200E-01 |
| N1-vs-N2 |
9.030000E-02 |
|
|
